LLY
-
Eli Lilly Stock Faces ‘Reduce’ Warning Amid Mixed Data
Eli Lilly stock navigates a volatile week as positive clinical data meets a sharp analyst downgrade, sparking debate over the future of the obesity drug market.
Eli Lilly stock navigates a volatile week as positive clinical data meets a sharp analyst downgrade, sparking debate over the future of the obesity drug market.